Actual Medicinal Product (AMP) - Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials (Waymade Healthcare Plc)

Navigation

Name Details

Name Start Date End Date
Name Current Name Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-12-2024 End Date
Previous Name Previous Name Risperdal Consta 37.5mg powder and solvent for suspension for injection vials Start Date 15-12-2006 End Date 30-11-2024
Abbreviated Name Abbreviated Name Risperdal Consta 37.5mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Risperdal Consta 37.5mg pdr & solv for susp for inj vials Previous Start Date 15-12-2006 Previous End Date 30-04-2009

Summary

Discontinued
Licensed Route
Intramuscular
Availability Restrictions
Not available
Licensing Authority
Medicines - MHRA/EMA
Parallel Import
Parallel Import Product
EMA Indicator

Codes

SNOMED Codes
Code Start Date End Date
10982311000001102 05-12-2006

Parent Products

Actual Medicinal Product Pack (AMPP) Information

Pack Size Indicative Price Discontinued
1 vial